Drug Type Small molecule drug |
Synonyms- |
Target- |
Action inhibitors |
Mechanism DNA synthesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13N3O4 |
InChIKeyPULHLIOPJXPGJN-BWVDBABLSA-N |
CAS Registry119804-96-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 3 | - | - | |
Colorectal Cancer | Phase 3 | - | - | |
Colorectal Cancer | Phase 3 | - | - | |
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Lung Cancer | Phase 2 | United States | - | - |